Leef Brands (LEEEF) Convertible Debt (2024)
Leef Brands (LEEEF) reported Convertible Debt of $10.0 million for Q4 2024.
Leef Brands (LEEEF) Convertible Debt (2024) Analysis & Trends
Leef Brands (LEEEF) has 1 years of Convertible Debt data on file, last reported at $10.0 million in Q4 2024.
- For the quarter ending Q4 2024, Convertible Debt changed N/A year-over-year to $10.0 million; the trailing twelve-month figure through Dec 2024 stood at $10.0 million (changed N/A YoY), and the FY2024 full-year result was $10.0 million, changed N/A from the prior year.
- Convertible Debt steadied at $10.0 million in Q4 2024.
- In the past five years, Convertible Debt ranged from a high of $10.0 million in Q4 2024 to a low of $10.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Leef Brands | 51.94 Mn | 46.18 Mn | 4.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 9.98 Mn |